FDA's 2026 general wellness guidance narrows device regulation for low-risk trackers but leaves significant privacy, security, and litigation risks.
| less than a minute read
FDA's 2026 Guidance on General Wellness Devices: Policy for Low-Risk Devices

/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-05-01-20-49-32-018-69f511dc2d6eff6dd1f0a7f4.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-05-01-19-25-44-978-69f4fe383c3d19adf4515ced.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-04-30-19-04-24-463-69f3a7b8e91b575190b29ecf.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-04-30-19-02-51-505-69f3a75bee3b827ef2acc5c7.jpg)